Application of a prostacyclin analogue (PG) and protease inhibitor (FUT) as anticoagulants with an LVAD system.
D000818:Animals; D000925:Anticoagulants; D001243:Assisted Circulation; D001550:Benzamidines; D001775:Blood Circulation; D001777:Blood Coagulation / Q000187:drug effects; D004285:Dogs; D011464:Epoprostenol / Q000627:therapeutic use* / Q000031:analogs & derivatives; D006146:Guanidines / Q000627:therapeutic use*; D006353:Heart-Assist Devices; D008168:Lung / Q000473:pathology; D010974:Platelet Aggregation / Q000187:drug effects; D011465:Prostaglandins, Synthetic / Q000627:therapeutic use*; D011474:Prosthesis Design; D011480:Protease Inhibitors / Q000627:therapeutic use*
D000925:Anticoagulants; D001550:Benzamidines; D006146:Guanidines; D011465:Prostaglandins, Synthetic; D011480:Protease Inhibitors; D011464:Epoprostenol; C035847:ataprost; C032855:nafamostat